SCHEMBL5180583

SCHEMBL5180583

CCNc1c(C(=O)N(C)c2ccccc2)c(=O)n(C)c2cccc(C)c12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 6/20 0.56
▸ KMT2A Q03164 6/20 0.56
▸ PGR P06401 1/20 0.56
▸ SRC P12931 1/20 0.48
▸ MAP3K5 Q99683 3/20 0.44
▸ MAPT P10636 3/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ USP2 O75604 2/20 0.44
▸ LMNA P02545 2/20 0.44
▸ CASP1 P29466 2/20 0.44
▸ BRCA1 P38398 2/20 0.44
▸ HTT P42858 2/20 0.44
▸ RECQL P46063 2/20 0.44
▸ CASP7 P55210 2/20 0.44
▸ YWHAG P61981 1/20 0.44
▸ HBB P68871 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ HDAC4 P56524 1/20 0.43
▸ POLB P06746 4/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5165239 0.88 MEN1 (0.56) MEN1KMT2APGRSRCMAP3K5
SCHEMBL5167153 0.82 MEN1 (0.70) MEN1KMT2APGRSRCMAP3K5
SCHEMBL5165191 0.81 KMT2A (0.58) MEN1KMT2APGRSRCMAP3K5
SCHEMBL5164479 0.81 MEN1 (0.58) MEN1KMT2APGRSRCMAP3K5
SCHEMBL5166407 0.81 MEN1 (0.58) MEN1KMT2APGRSRCMAP3K5
SCHEMBL5165395 0.78 MEN1 (0.43) MEN1KMT2APGRMAP3K5MAPT
SCHEMBL5164579 0.77 MEN1 (0.43) MEN1KMT2APGRMAP3K5MAPT
SCHEMBL7721669 0.77 HDAC4 (0.55) MEN1KMT2APGRSRCMAPT
SCHEMBL5165180 0.76 MEN1 (0.47) MEN1KMT2APGRMAP3K5MAPT
SCHEMBL10677667 0.76 KMT2A (0.71) MEN1KMT2APGRSRCL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1224172-B1 DRUGS FOR THE TREATMENT OF MALIGNANT TUMOURS ACTIVE BIOTECH AB (SE) 2007-04-04 — — EP disclosed
US-6395750-B1 Includes laquinimod, N-ethyl-N-phenyl-1,2-dihydro-4-hydroxy-5-chloro-1-methyl-2-oxo-quinoline-3-carboxamide and its salts; breat or prostate cancer ACTIVE BIOTECH AB (SE) 2002-05-28 — — US disclosed
Send feedback